procainamide has been researched along with Breast Neoplasms in 2 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Segura-Pacheco, B | 1 |
| Trejo-Becerril, C | 1 |
| Perez-Cardenas, E | 1 |
| Taja-Chayeb, L | 1 |
| Mariscal, I | 1 |
| Chavez, A | 1 |
| Acuña, C | 1 |
| Salazar, AM | 1 |
| Lizano, M | 1 |
| Dueñas-Gonzalez, A | 1 |
| Altundag, O | 1 |
| Altundag, K | 1 |
| Gunduz, M | 1 |
2 other studies available for procainamide and Breast Neoplasms
| Article | Year |
|---|---|
Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Breast Neoplasms; Cell Cycle; Cyclin-Dependen | 2003 |
DNA methylation inhibitor, procainamide, may decrease the tamoxifen resistance by inducing overexpression of the estrogen receptor beta in breast cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; DNA Methylation; Drug Resistance, | 2004 |